Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could lead to hypomethylation of the OR51G2 gene by direct inhibition of DNA methyltransferases, resulting in transcriptional repression of OR51G2. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
By selectively binding to DNA sequences rich in guanine and cytosine, Mithramycin A might block transcription factor access to the OR51G2 promoter, thereby silencing this gene′s expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may prevent the deacetylation of histones associated with the OR51G2 gene, leading to condensed chromatin and consequent transcriptional silencing of OR51G2. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, could induce hyperacetylation of histones at the OR51G2 locus, which may repress transcriptional initiation of this gene. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
By intercalating into DNA, Actinomycin D could obstruct the advancement of RNA polymerase along the OR51G2 gene, leading to a cessation of OR51G2 mRNA production. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 may prevent the methylation of cytosine-phosphate-guanine (CpG) islands near the OR51G2 promoter, causing a decrease in the transcriptional activity of this gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By incorporating into DNA and inhibiting methyltransferases, 5-Aza-2′-Deoxycytidine (Decitabine) might lead to reduced methylation levels at the OR51G2 promoter, causing a decrease in gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin (Sirolimus) could disrupt the mTOR signaling pathway, which is crucial for protein synthesis; this disruption might lead to a decrease in OR51G2 protein levels. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $182.00 $661.00 | 10 | |
Chetomin impedes the formation of the transcriptional complex at hypoxia-responsive elements, which could result in the downregulation of OR51G2 if it is under such control. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) could alter the expression of OR51G2 by causing an accumulation of acetylated histones, leading to a compact chromatin structure and transcriptional repression of the gene. |